Sensible Medical Innovation raises $7m

The company is developing a non-invasive device for monitoring congestive heart failure.

Sensible Medical Innovation, which is developing a non-invasive device for monitoring congestive heart failure (CHF), has raised $7 million from the Genesis and Vitalife funds.

The company was founded in 2007 by Amir Ronen, CEO, Dan Rappaport, chief scientist, Amir Soroka, Nadav Mizrahi, and Shlomi Bergida. The product has been successfully tested on animals and is now ready for human trials.

According to the company, the imaging method it has developed for internal organs is based on "unique Israeli capabilities in information technology" which it is not yet revealing. The combination of medical and information technology fits the joint investment by Vitalife, which specializes in healthcare, and Genesis, which specializes in communications.

At present there is no non-invasive solution for monitoring heart failure. In recent years, implanted devices for this purpose have reached the market, including one developed by Rimon Medical, which was sold to Boston Scientific for $80 million.

Sensible Medical Innovation recently won a $500,000 grant from the Global Cardiovascular Innovation Center, which is led by the Cleveland Clinic in the US.

Published by Globes [online], Israel business news - www.globes.co.il - on June 24, 2009

© Copyright of Globes Publisher Itonut (1983) Ltd. 2009

5 Comments
View comments in rows
Update by email about comments talkback
POST
Comments
Your name
Please insert your name
Content
Hyperlink in a new window Hyperlink Right Left underline italic bold Bulleted List Ordered List Face1 Face2 Face3 Face4 Face5 Face6
Your comment

Thanks
You comment was recieved and soon will be published.
In posting comments, I agree to abide by the Terms of Use
Globes encourages lively and frank debate, but posts that the editors consider merely abusive or otherwise inappropriate will be removed. Report inappropriate content
Thank you for posting your comment, which will be reviewed for publication.
Loading Comments...load
Load more comments
Twitter Facebook Linkedin RSS Newsletters גלובס Israel Business Conference 2016